-
UCB Taps Cradle for AI Antibody Design, Insilico Medicine Releases Open Source Longevity AI System
Nov 14 | Bio-IT World | Boston Children's Hospital and the University of Oxford to lead a $46M Genetic Medicines Hub within the ARIA autism research ecosystem; MD Anderson partners with P-Cure on compact proton and helium ion therapy; Takeda joins ISSCR consortium on stem cell-based models for drug discovery; Harvard Medical School team builds AI co-scientists for cancer research; Ascidian taps Exegenesis Bio for AAV capsids; new products from IDT, Aldevron, Lab Thread, and Licklider; and more. More -
A LEGO-style approach to building virus-like particles in insect cells
Nov 13 | Bio-IT World | Maren Schubert’s lab at the Helmholtz Center for Infection Research has spent a decade refining an alternative to the field’s default route for making virus-like particles (VLPs) in insect cells. Her solution: skip the virus. More -
Biosecurity Is Too Important to Be Left Unregulated
Nov 11 | Bio-IT World | Recently, California became the first state to enact a law requiring nucleic acid synthesis companies to screen sequences and vet customers before delivering their products. California is a pioneer in creating enforceable regulations of nucleic acid synthesis screening. Unfortunately, it’s not enough. More -
NCOA7 Emerges as Drug Target Linking Pulmonary Hypertension to Brain Inflammation
Nov 10 | Bio-IT World | A Pitt cardiologist’s startup, Amlysion Therapeutics, plans to develop NCOA7-activating drugs after new research traces cognitive decline in pulmonary hypertension to the same inflammatory pathway that drives the disease in the heart and lungs. More -
Fresenius WuXi Biologics Partner, Pfizer Deploys Edison's AI Scientist, Ultima, Illumina Win Singapore National Sequencing Award
Nov 07 | Bio-IT World | HuBMAP data portal opens 9,000 healthy-tissue datasets to researchers; NCI awards Montefiore Einstein $10 million to study breast cancer dormancy; UCB adds Cradle's protein design platform across its antibody discovery pipeline; NIH funds a $16.4 million hepatitis C vaccine center at Scripps Research; Transpharmation acquires organoid developer OrganoTherapeutics; new gene editing products from Integrated DNA Technologies and Aldevron; and more. More -
Gxp Compliance Support Is Coming To The Public Cloud. That’s Good For Life Sciences
Nov 05 | Bio-IT World | Emerging public-cloud ERP-based GxP compliance solutions will be good for life sciences businesses beyond just sharply reducing compliance overhead. Public-cloud ERP GxP will ensure product quality and patient safety, speed up innovation, stoke growth, appeal to investors, improve responsiveness to market moves, smooth M&A efforts, and enable AI-driven efficiencies. More -
Quantifying the Average Human Genome
Nov 03 | Bio-IT World | Mining two mega-datasets totaling over 900,000 sequenced genomes, researchers in the UK produced the broadest look yet at what a typical human genome contains and found that “normal” can look alarming on paper. “Variation is the norm,” they found. The work was published October in Genome Medicine. More -
Regulatory Affairs Is the Connective Tissue Pharma’s AI Strategy Is Missing
Oct 29 | Bio-IT World | Every major pharma organization I’ve come across in recent years has its own version of the same AI-based ambition. It is looking to use the technology to compress the R&D timeline, reduce late-stage attrition, and make regulatory submissions faster and inspections less tense. And yet, almost without exception, progress will stall because the product data foundations are flawed. More -
Follow the Money: OMass Raises Series C, Pathos AI Drug Development, Owkin Alums Launch Rivercell
Oct 28 | Bio-IT World | Matchpoint Therapeutics closes $150M Series B for oral autoimmune drugs; Soufflé Therapeutics raises $135M to take siRNA beyond the liver; WhiteLab Genomics adds $26M for AI-designed gene therapy delivery; and more. More -
ParkourSC Acquires Quartic, PacBio Partners with Verily, CAS Data Arrives in Microsoft Copilot
Oct 27 | Bio-IT World | Carterra and AstraZeneca collaborate on lab-in-the-loop drug discovery; Ultima Genomics is selected for an 80,000-sample UK Biobank immune profiling study; Hansa Biopharma taps Cradle for AI protein design; Genedata adds NVIDIA protein design models to its discovery workflows; Dotmatics reaches Databricks Gold status; new products from Revvity, Benchling, and Nabsys; and more. More
Corning’s MSCulture Max media increases final hMSC yields, streamlines culture, reduces in-process risk, and eliminates media exchanges, enabling higher cell expansion with less media and fewer media changes. The MSCulture Max media consists of a basal medium and supplement with 3 versions available:
- Standard research-grade medium for MSC expansion
- Xeno-free medium optimized for rapid MSC expansion
- Xeno-free GMP-grade medium for bioproduction
Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
Listen today!
